Patent · US Active

Method for diagnosis and/or prognosis of a septic syndrome

US11821038B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

BIOMERIEUX, INC. · FR

Inventors

Alexandre Pachot · Mâcon, FR
Guillaume Monneret · L'Essart Mador, FR
Alain Lepape · Saint-Genis-Laval, FR

Key dates

Filing date	Mar 12, 2021
Grant date	Nov 21, 2023
Priority date	—
Expiry date	Aug 9, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/26
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed herein is a method for the diagnosis/prognosis of a septic syndrome based on a biological sample from a patient. The method may include extracting biological material the biological sample, contacting the biological material with at least one specific reagent that is selected from specific reagents for the target genes having a nucleic acid sequence of any one of SEQ ID NOs: 1 to 28, and determining the expression of at least one of the target genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.